Status:

RECRUITING

Measuring Adverse Pregnancy and Newborn Congenital Outcomes

Lead Sponsor:

Indiana University

Conditions:

HIV/AIDS

Pregnancy Related

Eligibility:

FEMALE

Brief Summary

The purpose of this study is to develop a pharmacovigilance (PV) surveillance program to monitor adverse pregnancy and infant outcomes, including the presence of congenital abnormalities, among HIV-po...

Detailed Description

In part 1 of this study, the investigators will use a mixed prospective and cross-sectional cohort study design to implement a PV program at two health facilities affiliated with the Academic Model Pr...

Eligibility Criteria

Inclusion

  • C1. Prospective recruitment of HIV+ and HIV- pregnant women enrolling in ANC at the site:
  • Inclusion criteria for women
  • Pregnant and enrolled in ANC at the study site;
  • Understands English or Swahili.
  • Exclusion criteria for women a. Any physical or mental disability that prevents the woman from providing informed consent
  • Inclusion criteria for infants
  • a. All infants at any gestational age who are born to enrolled women will be included Exclusion criteria for infants (none)
  • C2. Data collection for all deliveries at the site:
  • Inclusion criteria for women a. Woman delivers at the site and the delivery is registered at the site
  • Exclusion criteria for women (none)
  • Inclusion criteria for live/stillborn infants
  • a. Infant is delivered at the site and results in the infant/stillbirth being registered at the site
  • Exclusion criteria for infants (none)
  • C3. Photos/videos of infants with CAs:
  • Inclusion criteria for infants
  • The infant is live or stillborn at ≥ 24 weeks estimated gestational age
  • The infant has a suspected CA on surface exam
  • Exclusion criteria for infants (none)

Exclusion

    Key Trial Info

    Start Date :

    September 29 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 31 2026

    Estimated Enrollment :

    2800 Patients enrolled

    Trial Details

    Trial ID

    NCT04405700

    Start Date

    September 29 2020

    End Date

    May 31 2026

    Last Update

    August 19 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Moi Teaching and Referral Hospital

    Eldoret, Kenya, 30100